Use of selegiline

PDMED_SELEGILINE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BD01

1340

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

995

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

995

diagram downward connector

Include endpoints None

995

diagram downward connector
PDMED_SELEGILINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
?
Number of individuals
979 415 564
?
Unadjusted prevalence (%)
0.32 0.24 0.42
?
Mean age at first event (years)
63.76 62.32 64.82

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 3.99 [3.08, 5.17] 1.3e-25 270
15 years 0.02 2.73 [2.09, 3.56] 1.1e-13 174
5 years 0.00 2.52 [1.82, 3.50] 3.0e-8 66
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PDMED_SELEGILINE – Use of selegiline
GWS hits:

Survival analyses between endpoints

Plot

before Use of selegiline
after Use of selegiline

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of selegiline